STRO logo

Sutro Biopharma (STRO) Cash From Investing

Annual CFI

-$3.92 M
+$31.10 M+88.80%

December 31, 2023

Summary

Performance

1-Year Change

+88.8%

3-Year Change

-749.67%

5-Year Change

+95.11%

15-Year Change

-112.04%

STRO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.17%
STRO annual cash flow from investing activities is higher than 39.17% of companies in Healthcare sector

High & Low

All-time High

$32.60 M
STRO annual cash flow from investing activities is currently -112.04% below its historical high of $32.60 million

3-Year Low

-$97.31 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
STRO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 25, 2025
STRO next annual earnings announcement is scheduled for Mar 25, 2025

OtherSTROcash flowmetrics:

Annual CFF

$137.55 M
STRO annual cash flow from financing activities is $137.55 million

Annual CFO

-$111.62 M
STRO annual cash flow from operations is -$111.62 million

Annual FCF

-$115.93 M
STRO annual free cash flow is -$115.93 million

Annual CAPEX

$4.32 M
STRO annual capital expenditures is $4.32 million

Quarterly CFI

$147.29 M
+$227.66 M+283.25%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+726.42%

3-Year Change

+726.42%

5-Year Change

+726.42%

STRO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.71%
STRO quarterly cash flow from investing activities is higher than 98.71% of companies in Healthcare sector

High & Low

All-time High

$147.29 M
STRO quarterly cash flow from investing activities is currently at an all-time high

3-Year Low

-$114.02 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
STRO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 25, 2025
STRO next earnings announcement is scheduled for Mar 25, 2025

OtherSTROcash flowmetrics:

Quarterly CFF

$1.02 M
STRO quarterly cash flow from financing activities is $1.02 million

Quarterly CFO

-$64.52 M
STRO quarterly cash flow from operations is -$64.52 million

Quarterly FCF

-$65.34 M
STRO quarterly free cash flow is -$65.34 million

Quarterly CAPEX

$828.00 K
STRO quarterly capital expenditures is $828.00 thousand

TTM CFI

$107.51 M
+$261.31 M+169.90%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+2839.73%

3-Year Change

+2839.73%

5-Year Change

+2839.73%

STRO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

94.92%
STRO TTM cash flow from investing activities is higher than 94.92% of companies in Healthcare sector

High & Low

All-time High

$107.51 M
STRO TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-$153.80 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
STRO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 25, 2025
STRO next earnings announcement is scheduled for Mar 25, 2025

OtherSTROcash flowmetrics:

TTM CFF

$90.95 M
STRO TTM cash flow from financing activities is $90.95 million

TTM CFO

-$105.73 M
STRO TTM cash flow from operations is -$105.73 million

TTM FCF

-$109.20 M
STRO TTM free cash flow is -$109.20 million

TTM CAPEX

$3.47 M
STRO TTM capital expenditures is $3.47 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

STRO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+88.8%+726.4%+2839.7%
3 y3 years-749.7%+726.4%+2839.7%
5 y5 years+95.1%+726.4%+2839.7%

STRO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+96.0%at high+229.2%at high+169.9%
5 y5-year-749.7%+96.0%at high+221.0%at high+166.1%
alltimeall time-112.0%+96.0%at high+221.0%at high+166.1%

Sutro Biopharma Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$147.29 M(-283.3%)
$107.51 M(-169.9%)
Jun 2024
-
-$80.38 M(-225.4%)
-$153.80 M(+2015.6%)
Mar 2024
-
$64.11 M(-372.6%)
-$7.27 M(+85.3%)
Dec 2023
-$3.92 M(-88.8%)
-$23.51 M(-79.4%)
-$3.92 M(-78.5%)
Sep 2023
-
-$114.02 M(-272.3%)
-$18.29 M(-203.4%)
Jun 2023
-
$66.16 M(-1.9%)
$17.69 M(-3298.7%)
Mar 2023
-
$67.45 M(-278.1%)
-$553.00 K(-98.4%)
Dec 2022
-$35.02 M(-64.0%)
-$37.88 M(-51.5%)
-$35.02 M(-248.1%)
Sep 2022
-
-$78.04 M(-262.9%)
$23.64 M(-76.2%)
Jun 2022
-
$47.91 M(+45.3%)
$99.44 M(+73.2%)
Mar 2022
-
$32.98 M(+58.7%)
$57.40 M(-159.0%)
Dec 2021
-$97.31 M
$20.78 M(-1026.9%)
-$97.31 M(-4.9%)
Sep 2021
-
-$2.24 M(-138.2%)
-$102.29 M(+2.5%)
Jun 2021
-
$5.88 M(-104.8%)
-$99.75 M(-38.7%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$121.73 M(-870.1%)
-$162.76 M(<-9900.0%)
Dec 2020
$604.00 K(-101.2%)
$15.81 M(+5240.2%)
$604.00 K(-108.3%)
Sep 2020
-
$296.00 K(-100.5%)
-$7.26 M(-422.0%)
Jun 2020
-
-$57.14 M(-237.2%)
$2.25 M(-96.7%)
Mar 2020
-
$41.64 M(+424.3%)
$68.58 M(-234.1%)
Dec 2019
-$51.13 M(-36.2%)
$7.94 M(-19.1%)
-$51.13 M(-10.4%)
Sep 2019
-
$9.81 M(+6.7%)
-$57.05 M(-61.6%)
Jun 2019
-
$9.19 M(-111.8%)
-$148.68 M(-5.8%)
Mar 2019
-
-$78.08 M(-3955.8%)
-$157.91 M(+96.9%)
Dec 2018
-$80.19 M(-346.0%)
$2.02 M(-102.5%)
-$80.19 M(-2.5%)
Sep 2018
-
-$81.81 M(>+9900.0%)
-$82.22 M(>+9900.0%)
Jun 2018
-
-$36.00 K(-90.1%)
-$400.00 K(+9.9%)
Mar 2018
-
-$364.00 K
-$364.00 K
Dec 2017
$32.60 M(+239.9%)
-
-
Dec 2016
$9.59 M
-
-

FAQ

  • What is Sutro Biopharma annual cash flow from investing activities?
  • What is the all time high annual CFI for Sutro Biopharma?
  • What is Sutro Biopharma annual CFI year-on-year change?
  • What is Sutro Biopharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Sutro Biopharma?
  • What is Sutro Biopharma quarterly CFI year-on-year change?
  • What is Sutro Biopharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Sutro Biopharma?
  • What is Sutro Biopharma TTM CFI year-on-year change?

What is Sutro Biopharma annual cash flow from investing activities?

The current annual CFI of STRO is -$3.92 M

What is the all time high annual CFI for Sutro Biopharma?

Sutro Biopharma all-time high annual cash flow from investing activities is $32.60 M

What is Sutro Biopharma annual CFI year-on-year change?

Over the past year, STRO annual cash flow from investing activities has changed by +$31.10 M (+88.80%)

What is Sutro Biopharma quarterly cash flow from investing activities?

The current quarterly CFI of STRO is $147.29 M

What is the all time high quarterly CFI for Sutro Biopharma?

Sutro Biopharma all-time high quarterly cash flow from investing activities is $147.29 M

What is Sutro Biopharma quarterly CFI year-on-year change?

Over the past year, STRO quarterly cash flow from investing activities has changed by +$170.80 M (+726.42%)

What is Sutro Biopharma TTM cash flow from investing activities?

The current TTM CFI of STRO is $107.51 M

What is the all time high TTM CFI for Sutro Biopharma?

Sutro Biopharma all-time high TTM cash flow from investing activities is $107.51 M

What is Sutro Biopharma TTM CFI year-on-year change?

Over the past year, STRO TTM cash flow from investing activities has changed by +$111.43 M (+2839.73%)